Wednesday, February 27, 2013

Bloody Disgusting: Blood-Soaked First Look At Indie ‘The Harrowing’

Bloody Disgusting
Your #1 Source For All Things Horror
Blood-Soaked First Look At Indie 'The Harrowing'
Feb 27th 2013, 23:13

Highland Myst Entertainment and Wolfclan Productions are proud to announce their newest film, The Harrowing, a demonic, horror thriller currently filming on location in Dallas, Texas.

In the tradition of SHUTTER ISLAND and JACOB’S LADDER, THE HARROWING follows fallen-from-grace Vice Detective Ryan Calhoun. After a routine surveillance goes horribly wrong, Calhoun is accused of the ritualistic murder of his best friend and partner, a prostitute, and a corrupt Congressmen. Unhinged and tormented by demonic dreams, and bent on discovering the truth, Calhoun is admitted to a forensic hospital for observation where, his sanity slowly sipping away, he begins to uncover the darkest, most terrifying truth imaginable.

Directed by Jon Keeyes (AMERICAN NIGHTMARE, FALL DOWN DEAD), The Harrowing stars Matthew Tompkins (KILLING DOWN, MISSIONARY MAN) as Detective Calhoun, veteran horror actress Debbie Rochon (AMERICAN NIGHTMARE) as the schizophrenic, necrophiliac Ella, Damon Carney (THE LONE RANGER) as Detective Jack Myers, Michael Crabtree (TEMPLE GRANDIN, PLACES IN THE HEART) as Lt. Logan, Robert McCollum (SUBURBAN NIGHTMARE) as Detective Greenbaum, and Ambre Lowe (PHOBIA) as Calhoun’s wife, Anne. Further casting announcements are coming soon including the addition of a Horror Icon to play the head of the forensic hospital, the possibly villainous Dr. Whitney.

Filming is currently underway in Dallas with the Producers expecting to wrap principal photography in April, 2013.

TH3 1024x576 Blood Soaked First Look At Indie The Harrowing

TH2 1024x574 Blood Soaked First Look At Indie The Harrowing

Media files:
TH3
The Harrowing
You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment